{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:57:47Z","timestamp":1792612667053,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jceh.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:23:30Z","timestamp":1668806610000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD \u2013 An Umbrella Overview of Systematic Review of Meta-Analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Jieling","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai En","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Ning","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren Jun Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Yu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yock Yong","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.11.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jceh.2022.11.006_bib2","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","author":"Lim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.11.006_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of nonalcoholic fatty liver disease in patients with Type 2 diabetes: a call to action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2022.11.006_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.11.006_bib6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2022.11.006_bib7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de Novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"Ter Horst","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2022.11.006_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis","volume":"56","author":"Loomba","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jceh.2022.11.006_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/apt.16808","article-title":"Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis","volume":"55","author":"Ng","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.11.006_bib11","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0070","article-title":"NAFLD versus MAFLD: prevalence, outcomes and implications of a change in name","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-022-01027-5","article-title":"Comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease","author":"Chew","year":"2022","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.jceh.2022.11.006_bib13","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in non-alcoholic fatty liver disease","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-022-10319-6","article-title":"Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis","volume":"16","author":"Yong","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2022.11.006_bib15","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2021.0406","article-title":"NAFLD increases risk of carotid atherosclerosis and ischemic stroke. An updated meta-analysis with 135,602 individuals","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jceh.2022.11.006_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cld.2015.01.012","article-title":"Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma","volume":"19","author":"Noureddin","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.11.006_bib18","article-title":"Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated meta-analysis and systematic review","author":"Yong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.11.006_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib21","article-title":"European \u2018NAFLD Preparedness Index\u2019 \u2014 is Europe ready to meet the challenge of fatty liver disease?","volume":"3","author":"Lazarus","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2022.11.006_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jhep.2021.12.009","article-title":"Why are there no strategies for NAFLD?","volume":"76","author":"Byrne","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ecolecon.2006.06.015","article-title":"Using meta-analysis for benefits transfer: theory and practice","volume":"60","author":"Bergstrom","year":"2006","journal-title":"Ecol Econ"},{"key":"10.1016\/j.jceh.2022.11.006_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bjsports-2017-097621","article-title":"Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews","volume":"51","author":"Ioannidis","year":"2017","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jceh.2022.11.006_bib25","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.11.006_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.11.006_bib27","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jceh.2022.11.006_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmj.316.7136.989","article-title":"When can odds ratios mislead?","volume":"316","author":"Davies","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.11.006_bib29","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 63","article-title":"Chapter 10: analysing data and undertaking meta-analyses","year":"2022"},{"key":"10.1016\/j.jceh.2022.11.006_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/bmj.39057.406644.68","article-title":"What is heterogeneity and is it important?","volume":"334","author":"Fletcher","year":"2007","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.jceh.2022.11.006_bib31","first-page":"177","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr Clin\u00a0Trials"},{"key":"10.1016\/j.jceh.2022.11.006_bib32","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.11.006_bib33","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1111\/hepr.12554","article-title":"Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: a meta-analysis","volume":"46","author":"Fan","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2022.11.006_bib34","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/MEG.0000000000000909","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Jaruvongvanich","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib35","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s10620-016-4125-2","article-title":"Significant association between gallstone disease and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"61","author":"Jaruvongvanich","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.11.006_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MEG.0000000000001684","article-title":"Nonalcoholic fatty liver disease\u00a0is\u00a0associated with intrahepatic cholangiocarcinoma and\u00a0not with\u00a0extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis","volume":"33","author":"Corrao","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211047074","article-title":"Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis","volume":"49","author":"Gong","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jceh.2022.11.006_bib38","article-title":"A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","author":"Toh","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.sleep.2020.04.004","article-title":"Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis","volume":"77","author":"Jullian-Desayes","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.jceh.2022.11.006_bib40","first-page":"10","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with peripheral diabetic polyneuropathy: a systematic review and meta-analysis","author":"Greco","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2022.11.006_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012092","article-title":"Non-alcoholic fatty liver disease and the risk of urolithiasis: a systematic review and meta-analysis","volume":"97","author":"Qin","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2022.11.006_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/MEG.0000000000001169","article-title":"Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib43","article-title":"Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease","volume":"8","author":"Xiao","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jceh.2022.11.006_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13158","article-title":"Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"49","author":"Xue","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2022.11.006_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.15087","article-title":"Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density","volume":"49","author":"Mantovani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.11.006_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.11.006_bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.diabet.2019.04.008","article-title":"Association between non-alcoholic fatty liver disease and decreased lung function in adults: a systematic review and meta-analysis","volume":"45","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jceh.2022.11.006_bib48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MEG.0000000000002299","article-title":"Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis","volume":"34","author":"Ciardullo","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.11.006_bib51","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.11.006_bib52","article-title":"Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis","volume":"9","author":"Liu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.11.006_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.11.006_bib54","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14461","article-title":"Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation","volume":"40","author":"Cai","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.11.006_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib56","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"suppl l","key":"10.1016\/j.jceh.2022.11.006_bib57","first-page":"S186","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"Angulo","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.11.006_bib59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jceh.2022.11.006_bib60","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib61","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.11.006_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050717","article-title":"Non-alcoholic fatty liver disease and extra-hepatic cancers","volume":"17","author":"Sanna","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2022.11.006_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-med-121211-091527","article-title":"Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression","volume":"64","author":"Gilbert","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jceh.2022.11.006_bib66","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.11.006_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.11.006_bib68","article-title":"Gallstone disease and its association with nonalcoholic fatty liver disease, all-cause and cause-specific mortality","author":"Konyn","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.11.006_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1445-5994.2012.02848.x","article-title":"Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists","volume":"43","author":"Bergqvist","year":"2013","journal-title":"Intern Med J"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:29Z","timestamp":1760854109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0973688322005175"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.11.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD \u2013 An Umbrella Overview of Systematic Review of Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}